333 related articles for article (PubMed ID: 31087601)
1. The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study.
Markousis-Mavrogenis G; Tromp J; Ouwerkerk W; Devalaraja M; Anker SD; Cleland JG; Dickstein K; Filippatos GS; van der Harst P; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; Zannad F; Zwinderman AH; Hillege HL; van Veldhuisen DJ; Kakkar R; Voors AA; van der Meer P
Eur J Heart Fail; 2019 Aug; 21(8):965-973. PubMed ID: 31087601
[TBL] [Abstract][Full Text] [Related]
2. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
[TBL] [Abstract][Full Text] [Related]
3. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction.
Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Solomon SD; Dickstein K; Atar D; Agewall S; Girerd N;
Am Heart J; 2019 Sep; 215():83-90. PubMed ID: 31291604
[TBL] [Abstract][Full Text] [Related]
5. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
[TBL] [Abstract][Full Text] [Related]
6. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure.
Pascual-Figal DA; Bayes-Genis A; Asensio-Lopez MC; Hernández-Vicente A; Garrido-Bravo I; Pastor-Perez F; Díez J; Ibáñez B; Lax A
J Am Coll Cardiol; 2019 Mar; 73(9):1016-1025. PubMed ID: 30846095
[TBL] [Abstract][Full Text] [Related]
7. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
Kontogeorgos S; Thunström E; Johansson MC; Fu M
Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
[TBL] [Abstract][Full Text] [Related]
8. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
[TBL] [Abstract][Full Text] [Related]
9. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF.
Cunningham JW; Ferreira JP; Deng H; Anker SD; Byra WM; Cleland JGF; Gheorghiade M; Lam CSP; La Police D; Mehra MR; Neaton JD; Spiro TE; van Veldhuisen DJ; Greenberg B; Zannad F
JACC Heart Fail; 2020 May; 8(5):359-368. PubMed ID: 32171760
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Markers and Risk of Heart Failure With Reduced to Preserved Ejection Fraction.
Albar Z; Albakri M; Hajjari J; Karnib M; Janus SE; Al-Kindi SG
Am J Cardiol; 2022 Mar; 167():68-75. PubMed ID: 34986991
[TBL] [Abstract][Full Text] [Related]
12. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
13. Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across the Left Ventricular Ejection Fraction Spectrum.
Santos M; West E; Skali H; Forman DE; Nadruz W; Shah AM
J Card Fail; 2018 Nov; 24(11):753-762. PubMed ID: 30300684
[TBL] [Abstract][Full Text] [Related]
14. Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction.
Brann A; Janvanishstaporn S; Greenberg B
JAMA Cardiol; 2020 Sep; 5(9):1027-1035. PubMed ID: 32936274
[TBL] [Abstract][Full Text] [Related]
15. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
[TBL] [Abstract][Full Text] [Related]
16. ST2 elevation in heart failure, predictive of a high early mortality.
Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
[TBL] [Abstract][Full Text] [Related]
17. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
[TBL] [Abstract][Full Text] [Related]
18. Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance.
Cuthbert JJ; Pellicori P; Rigby A; Pan D; Kazmi S; Shah P; Clark AL
Eur J Heart Fail; 2018 Oct; 20(10):1426-1435. PubMed ID: 29943886
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population.
Chia YC; Kieneker LM; van Hassel G; Binnenmars SH; Nolte IM; van Zanden JJ; van der Meer P; Navis G; Voors AA; Bakker SJL; De Borst MH; Eisenga MF
J Am Heart Assoc; 2021 Jun; 10(11):e018549. PubMed ID: 33998283
[TBL] [Abstract][Full Text] [Related]
20. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
